Verastem Boosted After Positive Top-Line Data For Leukemia Treatment

By: via Benzinga
Verastem Inc (NASDAQ: VSTM) shares are trading higher by $1.14 (30 percent) at $4.99 in Wednesday's session. The catalyst for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.